These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38656211)

  • 1. Vaccines and monoclonal antibodies: new tools for malaria control.
    Miura K; Flores-Garcia Y; Long CA; Zavala F
    Clin Microbiol Rev; 2024 Jun; 37(2):e0007123. PubMed ID: 38656211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
    Wang LT; Pereira LS; Kiyuka PK; Schön A; Kisalu NK; Vistein R; Dillon M; Bonilla BG; Molina-Cruz A; Barillas-Mury C; Tan J; Idris AH; Francica JR; Seder RA
    PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP).
    Parums DV
    Med Sci Monit; 2021 Sep; 27():e934676. PubMed ID: 34511592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.
    Foquet L; Hermsen CC; van Gemert GJ; Van Braeckel E; Weening KE; Sauerwein R; Meuleman P; Leroux-Roels G
    J Clin Invest; 2014 Jan; 124(1):140-4. PubMed ID: 24292709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.
    Wang LT; Pereira LS; Flores-Garcia Y; O'Connor J; Flynn BJ; Schön A; Hurlburt NK; Dillon M; Yang ASP; Fabra-García A; Idris AH; Mayer BT; Gerber MW; Gottardo R; Mason RD; Cavett N; Ballard RB; Kisalu NK; Molina-Cruz A; Nelson J; Vistein R; Barillas-Mury C; Amino R; Baker D; King NP; Sauerwein RW; Pancera M; Cockburn IA; Zavala F; Francica JR; Seder RA
    Immunity; 2020 Oct; 53(4):733-744.e8. PubMed ID: 32946741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from
    Reeder SM; Bah MA; Tursi NJ; Brooks RC; Patel A; Esquivel R; Eaton A; Jhun H; Chu J; Kim K; Xu Z; Zavala F; Weiner DB
    Infect Immun; 2021 Sep; 89(10):e0072820. PubMed ID: 34152830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of a circumsporozoite protein-based malaria vaccine.
    Chatterjee D; Cockburn IA
    Expert Rev Vaccines; 2021 Feb; 20(2):113-125. PubMed ID: 33554669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-Directed AAV8 Booster Vaccine Expressing
    Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
    Front Immunol; 2021; 12():612910. PubMed ID: 34248928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
    Murugan R; Scally SW; Costa G; Mustafa G; Thai E; Decker T; Bosch A; Prieto K; Levashina EA; Julien JP; Wardemann H
    Nat Med; 2020 Jul; 26(7):1135-1145. PubMed ID: 32451496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody acts like short-term malaria vaccine.
    Cohen J
    Science; 2021 Aug; 373(6557):843. PubMed ID: 34413219
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).
    Livingstone MC; Bitzer AA; Giri A; Luo K; Sankhala RS; Choe M; Zou X; Dennison SM; Li Y; Washington W; Ngauy V; Tomaras GD; Joyce MG; Batchelor AH; Dutta S
    Sci Rep; 2021 Mar; 11(1):5318. PubMed ID: 33674699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a Genetically Modified Chimeric
    Miyazaki Y; Marin-Mogollon C; Imai T; Mendes AM; van der Laak R; Sturm A; Geurten FJA; Miyazaki S; Chevalley-Maurel S; Ramesar J; Kolli SK; Kroeze H; van Schuijlenburg R; Salman AM; Wilder BK; Reyes-Sandoval A; Dechering KJ; Prudêncio M; Janse CJ; Khan SM; Franke-Fayard B
    Front Cell Infect Microbiol; 2020; 10():591046. PubMed ID: 33392104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.
    Singh K; Burkhardt M; Nakuchima S; Herrera R; Muratova O; Gittis AG; Kelnhofer E; Reiter K; Smelkinson M; Veltri D; Swihart BJ; Shimp R; Nguyen V; Zhang B; MacDonald NJ; Duffy PE; Garboczi DN; Narum DL
    Commun Biol; 2020 Jul; 3(1):395. PubMed ID: 32709983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
    Hayashi CTH; Cao Y; Zavala F; Simonyan H; Young CN; Kumar N
    Vaccine; 2023 Nov; 41(46):6824-6833. PubMed ID: 37827967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for antibody recognition of the NANP repeats in
    Oyen D; Torres JL; Wille-Reece U; Ockenhouse CF; Emerling D; Glanville J; Volkmuth W; Flores-Garcia Y; Zavala F; Ward AB; King CR; Wilson IA
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10438-E10445. PubMed ID: 29138320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural vaccinology of malaria transmission-blocking vaccines.
    Patel PN; Tolia N
    Expert Rev Vaccines; 2021 Feb; 20(2):199-214. PubMed ID: 33430656
    [No Abstract]   [Full Text] [Related]  

  • 18. Circumsporozoite protein as a potential target for antimalarials.
    Fernández-Arias C; Mashoof S; Huang J; Tsuji M
    Expert Rev Anti Infect Ther; 2015 Aug; 13(8):923-6. PubMed ID: 26081442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ayadi I; Balam S; Audran R; Bikorimana JP; Nebie I; Diakité M; Felger I; Tanner M; Spertini F; Corradin G; Arevalo M; Herrera S; Agnolon V
    Front Immunol; 2020; 11():574330. PubMed ID: 33193361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.